- Organ
- Vessels
- Study type
- Laboratory / marker study
- Year
- [source needed]
- Preparation
- Vesugen (Lys-Glu-Asp)
- Class
- Short synthetic peptide
- PMID
- [source needed]
Methods
Endothelial preparations assessed for expression of a small marker panel after exposure to the tripeptide. Sample size: [source needed]
Findings
- Authors report shifts in the measured marker panel relative to control.
- No clinical cardiovascular endpoints were assessed.
What this does not show
- Markers are not events. Nothing here speaks to heart attacks or strokes.
- This is not a product endorsement.
Educational summary only. Not medical advice, and not a product endorsement. Read the source paper before you repeat anything here.